174 related articles for article (PubMed ID: 10225846)
1. A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis.
Bakhiet M; Ozenci V; Withagen C; Mustafa M; Fredrikson S; Link H
Clin Diagn Lab Immunol; 1999 May; 6(3):415-9. PubMed ID: 10225846
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment.
Ozenci V; Kouwenhoven M; Huang YM; Xiao B; Kivisäkk P; Fredrikson S; Link H
Scand J Immunol; 1999 May; 49(5):554-61. PubMed ID: 10320650
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis.
Vojdani A; Vojdani E; Cooper E
J Intern Med; 2003 Oct; 254(4):363-74. PubMed ID: 12974875
[TBL] [Abstract][Full Text] [Related]
4. IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis.
Wang X; Chen M; Wandinger KP; Williams G; Dhib-Jalbut S
J Immunol; 2000 Jul; 165(1):548-57. PubMed ID: 10861095
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS.
Zang YC; Yang D; Hong J; Tejada-Simon MV; Rivera VM; Zhang JZ
Neurology; 2000 Aug; 55(3):397-404. PubMed ID: 10932275
[TBL] [Abstract][Full Text] [Related]
6. T-cell interleukin-6 receptor binding in interferon-beta-1b-treated multiple sclerosis patients.
Bongioanni P; Lombardo F; Moscato G; Mosti S; Meucci G
Eur J Neurol; 2000 Nov; 7(6):647-53. PubMed ID: 11136350
[TBL] [Abstract][Full Text] [Related]
7. Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
Jansson A; Ernerudh J; Kvarnström M; Ekerfelt C; Vrethem M
Mult Scler; 2003 Oct; 9(5):440-5. PubMed ID: 14582766
[TBL] [Abstract][Full Text] [Related]
8. Role of interferons in demyelinating diseases.
Arnason BG; Toscas A; Dayal A; Qu Z; Noronha A
J Neural Transm Suppl; 1997; 49():117-23. PubMed ID: 9266421
[TBL] [Abstract][Full Text] [Related]
9. Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b.
Antonelli G; Simeoni E; Bagnato F; Pozzilli C; Turriziani O; Tesoro R; Di Marco P; Gasperini C; Fieschi C; Dianzani F
J Neurol Sci; 1999 Oct; 168(2):131-6. PubMed ID: 10526196
[TBL] [Abstract][Full Text] [Related]
10. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
Rohowsky-Kochan C; Molinaro D; Cook SD
Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
[TBL] [Abstract][Full Text] [Related]
11. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to interferon beta in patients with multiple sclerosis receiving CinnoVex, rebif, and betaferon.
Zare N; Zarkesh-Esfahani SH; Gharagozloo M; Shaygannejad V
J Korean Med Sci; 2013 Dec; 28(12):1801-6. PubMed ID: 24339712
[TBL] [Abstract][Full Text] [Related]
13. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis.
Trenova AG; Manova MG; Kostadinova II; Murdjeva MA; Hristova DR; Vasileva TV; Zahariev ZI
Folia Med (Plovdiv); 2011; 53(2):29-35. PubMed ID: 21797104
[TBL] [Abstract][Full Text] [Related]
15. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
Hedegaard CJ; Krakauer M; Bendtzen K; Sørensen PS; Sellebjerg F; Nielsen CH
Clin Immunol; 2008 Oct; 129(1):80-9. PubMed ID: 18653385
[TBL] [Abstract][Full Text] [Related]
16. Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients.
Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
Clin Diagn Lab Immunol; 1995 Nov; 2(6):766-9. PubMed ID: 8574845
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
18. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis.
Noronha A; Toscas A; Jensen MA
J Neuroimmunol; 1993 Jul; 46(1-2):145-53. PubMed ID: 8360326
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis.
Ossege LM; Sindern E; Patzold T; Malin JP
Int Immunopharmacol; 2001 Jun; 1(6):1085-100. PubMed ID: 11407304
[TBL] [Abstract][Full Text] [Related]
20. Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells.
Jiang H; Milo R; Swoveland P; Johnson KP; Panitch H; Dhib-Jalbut S
J Neuroimmunol; 1995 Aug; 61(1):17-25. PubMed ID: 7560008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
